BECKER CAPITAL MANAGEMENT INC Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$3.5T

Holdings

301

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (301 positions)

#StockSharesValue% PortfolioType
301
—REVIVA PHARMACEUTCLS HLDGS I
32,580$9.0M0.00%
PreviousPage 4 of 4